Home » CRYOFLUOR THERAPEUTICS CLOSES SECOND-ROUND INVESTMENT
CRYOFLUOR THERAPEUTICS CLOSES SECOND-ROUND INVESTMENT
CryoFluor Therapeutics, a medical device company developing a novel cryosurgical technology platform, has received a second investment that will allow the company to complete a feasibility clinical trial of its device to treat abnormal uterine bleeding. Research Corporation Technologies, Endocare and Temple University participated in the investment.
Yahoo News (http://biz.yahoo.com/bw/050106/65787_1.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct